Showing 71-80 of 7239 results for "".
ICD-10: Facts, Myths, and Solutions
https://practicaldermatology.com/topics/practice-management/facts-mythsand-solutions/21422/With the deadline for implementation of the new Medicare coding system just months away, physicians need to prepare their practices for a significant transition.Social Media: Mass Med Society
https://practicaldermatology.com/topics/practice-management/mass-med-society/19360/Massachusetts Medical Society: Social Media Pitfalls and Opportunities, including inadvertent disclosure and security.Success Steps: Undertaking the Medical Spa Challenge
https://practicaldermatology.com/topics/general-topics/success-steps-undertaking-the-medical-spa-challenge/21768/From location to menu offerings and more, here's the right way to enter the medical spa arena.Lasers In Practice: Reducing the Appearance of Stretch Marks with Multiple Laser Technologies
https://practicaldermatology.com/topics/general-topics/lasers-in-practice-reducing-the-appearance-of-stretch-marks-with-multiple-laser-technologies/21769/Traditionally difficult to treat, stretch marks may respond to a combination of modalities provided in sync.Medlite - What Physicians are Saying
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/medlite-what-physicians-are-saying/19453/Impressive statements from Doctors using the Medlite laser are given. The benefits and outcomes of specific cases are discussed.Advancing Digital Medicine in Dermatology
https://practicaldermatology.com/programs/practical-dermatology/advancing-digital-medicine-in-dermatology/18187/The Digital Medicine Society (DiME) is a global nonprofit dedicated to advancing the ethical, effective, equitable, and safe use of digital medicine to redefine health care and improve lives. DiME recently released a new set of resources, available at www.dimesociety.org/access-resources/, to advancJournal Club: Dupilumab and Risk of Malignancy
https://practicaldermatology.com/series/practical-dermatology-journal-club-atopic-dermatitis/journal-club-dupilumab-and-risk-of-malignancy/32398/Practical Dermatology Chief Medical Editor Neal Bhatia, MD, FAAD, speaks with Matthew Zirwas, MD, about the Journal of Allergy and Clinical Immunology: In Practice article "Risk of malignancy associated with use of dupilumab versus other treatments in atopic dermatitis patients: A national databaseHilary Baldwin, MD: Perspective on the FDA Citizen's Petition for Acne Products with Benzoyl Peroxide (BPO)
https://practicaldermatology.com/topics/acne-rosacea/hilary-baldwin-md-perspective-fda-citizens-petition-acne-products-benzoyl-peroxide-bpo/24171/Neal Bhatia, MD, chief medical editor of Practical Dermatology® talks to Hilary E. Baldwin, MD about a new report from an independent laboratory that finds benzene can form at unacceptably high levels in both over-the-counter and prescription medications that contain benzoyl peroxide.First Medication for Severe Frostbite; Biosimilar to Humira with Interchangeability Status Approved; Two Late-Stage AD Candidates Advance
https://practicaldermatology.com/series/dermwire-tv/first-medication-for-severe-frostbite-biosimilar-to-humira-with-interchangeability-status-approved-two-late-stage-ad-candidates-advance/20267/In this episode of DermWireTV, the first medication to treat severe frostbite is approved by the FDA; the first high-concentration biosimilar to Humira with interchangeability status will soon be available in the US; and two companies with late-stage atopic dermatitis candidates provide key updates.DermWireTV: Vtama Approved; Monkey Pox; AbbVie Scholarship; LRP Pride in Dermatology
https://practicaldermatology.com/topics/psoriasis/dermwiretv-vtama-approved-monkey-pox-abbvie-scholarship-lrp-pride-in-dermatology/20097/Vtama (tapinarof) cream 1% from Dermavant is approved for the treatment of psoriasis in adults. Tapinarof is an aryl hydrocarbon receptor agonist. As a public health service, VisualDx is offering pictures of monkey pox and disease information to support clinical decision-making. Forty-five scholarsh